Cumulus Neuroscience

Cumulus, led by CEO Ronan Cunningham, provides "real-world" clinical trial data and AI-driven insights through an integrated biomarker platform co-developed with some of the world's leading pharmaceutical companies. The company’s comprehensive solution is a platform capable of synchronously capturing frequent, longitudinal brain activity measurements in conjunction with functional and symptomatic domains outside of clinical settings, offering insights via AI technology to support clinical trial decision-making and execution. Built on proprietary expertise and partnerships within their field, it remotely captures vast amounts of real-world, lab-quality data. Throughout the duration of clinical trials, mobile device-based assessments and synchronized brain activity recordings track the full spectrum of drug mechanisms, neurophysiological functions, and patient symptoms, all conducted in the user’s home.